Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Grines

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Circulation|August 1, 1991
A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) GroupC L Grines, S E Nissen, D C Booth, et al.
The American Journal of Cardiology|July 13, 2001
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarctionM T Roe, F A Cura, P S Joski, et al.
Circulation|December 1, 1992
A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarctionW W O'Neill, R Weintraub, C L Grines, et al.
The American Journal of Cardiology|June 30, 1998
Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarctionT D Miller, D O Hodge, J M Sutton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1997
PET perfusion and vasodilator function after angioplasty for acute myocardial infarctionR E Stewart, D D Miller, T R Bowers, et al.
Journal of the American College of Cardiology|April 1, 1997
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsG W Stone, C L Grines, D Rothbaum, et al.
Arquivos Brasileiros De Cardiologia|January 19, 2002
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trialL A Mattos, C L Grines, J E Sousa, et al.
Circulation|February 1, 1987
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarctionE J Topol, W W O'Neill, A B Langburd, et al.
JAMA|December 24, 1997
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative reviewW D Weaver, R J Simes, A Betriu, et al.
The American Journal of Cardiology|June 27, 2000
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials)V S DeGeare, G W Stone, L Grines, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Circulation|August 1, 1991
A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) GroupC L Grines, S E Nissen, D C Booth, et al.
The American Journal of Cardiology|July 13, 2001
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarctionM T Roe, F A Cura, P S Joski, et al.
Circulation|December 1, 1992
A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarctionW W O'Neill, R Weintraub, C L Grines, et al.
The American Journal of Cardiology|June 30, 1998
Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarctionT D Miller, D O Hodge, J M Sutton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1997
PET perfusion and vasodilator function after angioplasty for acute myocardial infarctionR E Stewart, D D Miller, T R Bowers, et al.
Journal of the American College of Cardiology|April 1, 1997
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsG W Stone, C L Grines, D Rothbaum, et al.
Arquivos Brasileiros De Cardiologia|January 19, 2002
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trialL A Mattos, C L Grines, J E Sousa, et al.
Circulation|February 1, 1987
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarctionE J Topol, W W O'Neill, A B Langburd, et al.
JAMA|December 24, 1997
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative reviewW D Weaver, R J Simes, A Betriu, et al.
The American Journal of Cardiology|June 27, 2000
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials)V S DeGeare, G W Stone, L Grines, et al.
Pageof 12